Skip to main content
CRIS - Current Research Information System
Log In
Log in
New user? Click here to register.
Have you forgotten your password?
Communities & Collections
Research Outputs
Fundings & Projects
Researchers
Datasets
Statistics
Home
CRIS
Search
CRIS
Permanent URI for this community
https://investigadores.udd.cl/handle/123456789/1
Browse
Search
Subcommunities and Collections
Search
Subcommunities and Collections
3 results
Back to results
Filters
Type
3
Journal article
3
Text
Author
search.filters.author.Christian Caglevic
1
Al Benson
1
Ana Arance
1
Andrew H. Ko
1
Caroline Robert
Show more
Search author name
Submit
Subject
search.filters.subject.antineoplastic agent
3
Article
3
Human
3
Humans
2
Adult
Show more
Search subject
Submit
Browse subject tree
Date
Start
End
Submit
2019 - 2020
3
Submit
Has files
3
No
Item Type
3
Publication
Access type
3
Unknown
Reset filters
Settings
Sort By
Accessioned Date Descending
Most Relevant
Title Ascending
Date Issued Descending
Results per page
1
5
10
20
40
60
80
100
Search
Author: search.filters.author.Christian Caglevic
×
Subject: search.filters.subject.antineoplastic agent
×
Search Tools
Search Results
Now showing
1 - 3 of 3
Loading...
Loading...
Some of the metrics are blocked by your
consent settings
Item type:
Publication
,
Potential use of n-3 PUFAs to prevent oxidative stress-derived ototoxicity caused by platinum-based chemotherapy
(
2020
)
Ignacio A. Cortés Fuentes
;
Mauricio Burotto
;
Mauricio A. Retamal
;
Michael Frelinghuysen
;
Christian Caglevic
Show more
Scopus© Citations 4
1
Loading...
Loading...
Some of the metrics are blocked by your
consent settings
Item type:
Publication
,
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
(
2020
)
Kohei Shitara
;
Eric Van Cutsem
;
Yung-Jue Bang
;
Charles Fuchs
;
Lucjan Wyrwicz
Show more
37
Scopus© Citations 899
Loading...
Loading...
Some of the metrics are blocked by your
consent settings
Item type:
Publication
,
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
(
2019
)
Georgina V Long
;
Reinhard Dummer
;
Omid Hamid
;
Thomas F Gajewski
;
Christian Caglevic
Show more
Scopus© Citations 731
3